Clinical Trials in Youngstown, United States
Locations / Youngstown, United States
Delta Trials records 34 clinical trials conducted in Youngstown, United States, making it a notable site of clinical research activity. These trials across 325 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Youngstown has changed over time.
34
Total Trials
325
Conditions
0
Terminated since 2020
Browse by condition (325 total)
- Recurrent ovarian carcinoma 4 trialsAll Recurrent ovarian carcinoma trials
- Stage iiib lung cancer ajcc v8 4 trialsAll Stage iiib lung cancer ajcc v8 trials
- Chronic lymphocytic leukemia 3 trialsAll Chronic lymphocytic leukemia trials
- Stage iiia lung cancer ajcc v8 3 trialsAll Stage iiia lung cancer ajcc v8 trials
- Metastatic malignant solid neoplasm 3 trialsAll Metastatic malignant solid neoplasm trials
- Stage iv lung cancer ajcc v8 3 trialsAll Stage iv lung cancer ajcc v8 trials
- Small lymphocytic lymphoma 3 trialsAll Small lymphocytic lymphoma trials
- Bladder adenocarcinoma 2 trialsAll Bladder adenocarcinoma trials
- Endometrioid adenocarcinoma 2 trialsAll Endometrioid adenocarcinoma trials
- All Recurrent lung non-squamous non-small cell carcinoma trials
- Thyroid gland carcinoma 2 trialsAll Thyroid gland carcinoma trials
- Advanced malignant solid neoplasm 2 trialsAll Advanced malignant solid neoplasm trials
- All Anatomic stage iv breast cancer ajcc v8 trials
- Sarcomatoid renal cell carcinoma 2 trialsAll Sarcomatoid renal cell carcinoma trials
- Malignant solid neoplasm 2 trialsAll Malignant solid neoplasm trials
- All Stage iv cutaneous melanoma ajcc v6 and v7 trials
- All Primary peritoneal high grade serous adenocarcinoma trials
- All Recurrent ovarian endometrioid adenocarcinoma trials
- Recurrent malignant solid neoplasm 2 trialsAll Recurrent malignant solid neoplasm trials
- All Recurrent malignant uterine corpus neoplasm trials